mazdutide and tirzepatide together vs Tirzepatide: Which Weight Loss Drug is Best for ? (2025) Updates in Medicine | Mazdutide

In the GLORY-2 trial , adults with obesity taking mazdutide 9 mg lost an average of 18.6% of their body weight over 60 weeks , with no plateau observed by the end of the study

Patients with a personal or family history of thyroid cancer, multiple endocrine neoplasia type 2, or severe pancreatitis should not use tirzepatide

If a mother requires tirzepatide, it is not a reason to discontinue breastfeeding

This lack of coverage can make the medication more expensive for those without insurance

Tirzepatide may also be considered for adults struggling with obesity or overweight, especially if you have related health concerns such as high blood pressure, high cholesterol, or heart disease, and have not seen results from diet and exercise alone

A real-world study found new GERD development at a rate of 67.04 events per 1,000 person-years among tirzepatide users, compared to 51.46 in the comparison group